NeoGenomics Inc (NEO) stock
NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.25−0.16 (-1.04%)
Close on Nov 17, 2026Market cap $1.97BP/E –Yield –
NeoGenomics total assets
Total assets on the balance sheet at the end of each period.
NeoGenomics's total assets was $1.38B at Sep 30, 2026. For fiscal 2025 it was $1.36B, down 17.0% from the year before. Over ten years it grew 14.5% a year on average. The highest annual figure on record is $1.87B in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.36B | -17.0% |
| FY2024 | Dec 31, 2024 | $1.64B | -2.6% |
| FY2023 | Dec 31, 2023 | $1.68B | -3.4% |
| FY2022 | Dec 31, 2022 | $1.74B | -6.9% |
| FY2021 | Dec 31, 2021 | $1.87B | +89.2% |
| FY2020 | Dec 31, 2020 | $988.33M | +39.3% |
| FY2019 | Dec 31, 2019 | $709.51M | +40.5% |
| FY2018 | Dec 31, 2018 | $505.02M | +46.6% |
| FY2017 | Dec 31, 2017 | $344.45M | +2.2% |
| FY2016 | Dec 31, 2016 | $337.12M | -4.0% |
| FY2015 | Dec 31, 2015 | $351.29M | +333.1% |
| FY2014 | Dec 31, 2014 | $81.11M | +103.2% |
| FY2013 | Dec 31, 2013 | $39.92M | +32.7% |
| FY2012 | Dec 31, 2012 | $30.07M | +50.7% |
| FY2011 | Dec 31, 2011 | $19.95M | +46.1% |
| FY2010 | Dec 31, 2010 | $13.65M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.38B | +0.2% |
| Q2 FY2026 | Jun 30, 2026 | $1.35B | -3.0% |
| Q1 FY2026 | Mar 31, 2026 | $1.35B | -15.9% |
| Q4 FY2025 | Dec 31, 2025 | $1.36B | -17.0% |
| Q3 FY2025 | Sep 30, 2025 | $1.37B | -16.2% |
| Q2 FY2025 | Jun 30, 2025 | $1.39B | -15.2% |
| Q1 FY2025 | Mar 31, 2025 | $1.60B | -2.4% |
| Q4 FY2024 | Dec 31, 2024 | $1.64B | -2.6% |
| Q3 FY2024 | Sep 30, 2024 | $1.64B | -2.2% |
| Q2 FY2024 | Jun 30, 2024 | $1.64B | -3.1% |
| Q1 FY2024 | Mar 31, 2024 | $1.64B | -4.0% |
| Q4 FY2023 | Dec 31, 2023 | $1.68B | -3.4% |
| Q3 FY2023 | Sep 30, 2023 | $1.68B | -4.4% |
| Q2 FY2023 | Jun 30, 2023 | $1.70B | -5.4% |
| Q1 FY2023 | Mar 31, 2023 | $1.71B | -6.6% |
| Q4 FY2022 | Dec 31, 2022 | $1.74B | -6.9% |
| Q3 FY2022 | Sep 30, 2022 | $1.76B | -7.9% |
| Q2 FY2022 | Jun 30, 2022 | $1.79B | -5.5% |
| Q1 FY2022 | Mar 31, 2022 | $1.83B | +22.4% |
| Q4 FY2021 | Dec 31, 2021 | $1.87B | +89.2% |
| Q3 FY2021 | Sep 30, 2021 | $1.91B | +98.7% |
| Q2 FY2021 | Jun 30, 2021 | $1.90B | +100.6% |
| Q1 FY2021 | Mar 31, 2021 | $1.49B | +104.1% |
| Q4 FY2020 | Dec 31, 2020 | $988.33M | +39.3% |
| Q3 FY2020 | Sep 30, 2020 | $959.43M | +34.9% |
| Q2 FY2020 | Jun 30, 2020 | $945.49M | +35.7% |
| Q1 FY2020 | Mar 31, 2020 | $732.25M | +37.3% |
| Q4 FY2019 | Dec 31, 2019 | $709.51M | +40.5% |
| Q3 FY2019 | Sep 30, 2019 | $711.16M | +56.3% |
| Q2 FY2019 | Jun 30, 2019 | $696.67M | +101.5% |
| Q1 FY2019 | Mar 31, 2019 | $533.34M | +52.7% |
| Q4 FY2018 | Dec 31, 2018 | $505.02M | +46.6% |
| Q3 FY2018 | Sep 30, 2018 | $455.14M | +32.3% |
| Q2 FY2018 | Jun 30, 2018 | $345.78M | +1.7% |
| Q1 FY2018 | Mar 31, 2018 | $349.27M | +1.6% |
| Q4 FY2017 | Dec 31, 2017 | $344.45M | +2.2% |
| Q3 FY2017 | Sep 30, 2017 | $343.90M | – |
| Q2 FY2017 | Jun 30, 2017 | $339.88M | – |
| Q1 FY2017 | Mar 31, 2017 | $343.64M | – |
| Q4 FY2016 | Dec 31, 2016 | $337.12M | – |
See a number that looks wrong?